Skip to content

Optimization and application of Taijiquan exercise prescription based on "dose-effect" relationship in promoting cardiovascular health in diabetic patients

Optimization and application of Taijiquan exercise prescription based on "dose-effect" relationship in promoting cardiovascular health in diabetic patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001103
Enrollment
Unknown
Registered
2025-06-03
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

High-frequency training group:24 simplified Tai Chi 60 minutes each time 5 times a week for 24 consecutive weeks. They will not participate in other special physical exercises during the study period.
Regular training group:24 simplified Tai Chi 60 minutes each time 3 times a week for 24 consecutive weeks. They will not participate in other special physical exercises during the study period.

Sponsors

The Second People's Affiliated Hospital of Fujian University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Age 40-70 years old regardless of gender; 2) Meet the diagnostic criteria for type 2 diabetes and the duration of diabetes is =5 years; 3) The limbs are sound no contraindications for exercise and no contraindications for treadmill test; 4) There is no serious audio-visual or cognitive impairment and can cooperate with the completion of various examinations; 4) Agree to join the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Acute metabolic complications such as severe hypoglycemia and diabetic ketoacidosis combined with acute infection proliferative retinopathy severe cardiovascular and cerebrovascular diseases (unstable angina pectoris severe arrhythmia transient ischemic attack) severe diabetic foot etc.; 2) Being taking other drugs that affect glycolipid metabolism in addition to hypoglycemic drugs such as steroids diuretics etc.; 3) Women during pregnancy or lactation; 4) Suffering from nerve muscle joint and other diseases that affect motor function; 3) Complicated with serious primary diseases or malignant tumors such as liver kidney blood or endocrine system; 4) The cumulative amount of regular exercise time per week for the three months before enrollment exceeded 1.5 hours. Anyone who meets any of the above conditions will be excluded from the study. 5) Complicated with serious primary diseases or malignant tumors such as liver kidney blood or endocrine system; 6) The cumulative amount of regular exercise time per week for the three months before enrollment exceeded 1.5 hours. Anyone who meets any of the above conditions will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Muscle function indicators;CVD risk factor indicators;

Countries

China

Contacts

Public ContactLianHua Yin

The Second People's Affiliated Hospital of Fujian University of Traditional Chinese Medicine

13214759@qq.com+86 186 0601 3672

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026